The impact of Human Epidermal growth factor Receptor 2 (HER2) expression by RT-PCR on tumor characteristics and outcome in estrogen receptor (ER) positive, HER2 negative early-stage breast cancer

被引：0
|
作者：
Goldvaser, Hadar
Mutai, Raz
Stemmer, Salomon
Kuchuk, Iryna
Tokar, Margarita
Paluch-Shimon, Shani
Yerushalmi, Rinat
Drumea, Karen
Evron, Ella
Sonnenblick, Amir
Gal-Yam, Einav
Bar Sela, Gil
Shai, Ayelet
Merose, Rotem
Bareket-Samish, Avital
Soussan-Gutman, Lior
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 09期
关键词：
D O I：
10.1158/1538-7445.SABCS23-PO5-01-08
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO5-01-08
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Impact of estrogen receptor (ER) and human epidermal growth factor receptor-2 (HER2) co-expression on breast cancer disease characteristics: implications for tumor biology and research
    Abeer Alqaisi
    Li Chen
    Edward Romond
    Mara Chambers
    Mark Stevens
    Grace Pasley
    Mukta Awasthi
    Suleiman Massarweh
    Breast Cancer Research and Treatment, 2014, 148 : 437 - 444
  • [2] Impact of estrogen receptor (ER) and human epidermal growth factor receptor-2 (HER2) co-expression on breast cancer disease characteristics: implications for tumor biology and research
    Alqaisi, Abeer
    Chen, Li
    Romond, Edward
    Chambers, Mara
    Stevens, Mark
    Pasley, Grace
    Awasthi, Mukta
    Massarweh, Suleiman
    BREAST CANCER RESEARCH AND TREATMENT, 2014, 148 (02) : 437 - 444
  • [3] The human epidermal growth factor receptor 2 (HER2)
    Tafe, Laura J.
    Tsongalis, Gregory J.
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2012, 50 (01) : 23 - 30
  • [4] Comparison of HER2 Testing by IHC/FISH and RT-PCR in Estrogen Receptor (ER) Negative or Borderline Patients (pts) with Early Stage Breast Cancer (ESBC)
    Singh, B.
    Ziguridis, N.
    Butler, S.
    Jamshidian, F.
    Cherbavaz, D.
    Sing, A.
    LABORATORY INVESTIGATION, 2013, 93 : 70A - 70A
  • [5] Comparison of HER2 Testing by IHC/FISH and RT-PCR in Estrogen Receptor (ER) Negative or Borderline Patients (pts) with Early Stage Breast Cancer (ESBC)
    Singh, B.
    Ziguridis, N.
    Butler, S.
    Jamshidian, F.
    Cherbavaz, D.
    Sing, A.
    MODERN PATHOLOGY, 2013, 26 : 70A - 70A
  • [6] Clinical impact of epidermal growth factor receptor (EGFR) coexpression in early breast cancer with human epidermal growth factor receptor 2 (HER2) overexpression
    Park, S.
    Cho, E.
    Shin, Y.
    Hong, S.
    Lee, M.
    Park, Y.
    Nam, S.
    Yang, J.
    Choi, Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [7] Analysis of clinicopathological characteristics and prognostic factors of early-stage human epidermal growth factor receptor 2 (HER2)-low breast cancer: Compared with HER2-0 breast cancer
    Wu, Qian
    Yang, Fan
    Liu, Yinhua
    Zhang, Hong
    Zhang, Shuang
    Xin, Ling
    Xu, Ling
    CANCER MEDICINE, 2023, 12 (19): : 19560 - 19575
  • [8] Updates in hormone-receptor-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced breast cancer in 2021
    Mezni, Essia
    Sabatier, Renaud
    Goncalves, Anthony
    Vicier, Cecile
    BULLETIN DU CANCER, 2022, 109 (02) : 216 - 225
  • [9] Explanation model using pathological data for treatment outcome of patients with early-stage breast cancer with hormonal receptor (HR)-positive and human epidermal growth factor receptor 2 (HER2)-negative.
    Prasongsook, Naiyarat
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [10] De-Escalating Treatment Strategies for Patients with Human Epidermal Growth Factor Receptor-2 (HER2)-Positive Early-Stage Breast Cancer
    Abdel-Razeq, Hikmat
    CANCERS, 2024, 16 (20)
12345